JUSTIN BATES: Open Payments
NPI 1639852676 · CLIFTON PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,596 in 97 payments from 12 companies in 2025. Trend: 2023 $640 · 2024 $2,452 · 2025 $2,596
Food & beverage: $2,596
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $928 |
| Janssen Biotech, Inc. | 26 | $520 |
| AstraZeneca Pharmaceuticals LP | 15 | $290 |
| UCB, Inc. | 10 | $289 |
| Janssen Scientific Affairs, LLC | 1 | $116 |
| Mallinckrodt Hospital Products Inc. | 5 | $116 |
| PFIZER INC. | 3 | $101 |
| Novartis Pharmaceuticals Corporation | 3 | $79 |
| Aurinia Pharma U.S., Inc. | 3 | $70 |
| Amgen Inc. | 2 | $34 |
Products named: TREMFYA, RINVOQ, SKYRIZI, SAPHNELO, Bimzelx, ACTHAR, XELJANZ, COSENTYX.
Industry payments across NY — which companies pay providers there.
